Dirk Dressler, MD, PhD, obtained his medical education at Georg-August University, Goettingen, Friedrich-Alexander University, Erlangen and at Harvard Medical School, Boston, MA. He is a fully board certified neurologist and psychiatrist. After several years of postgraduate training at the National Hospital for Neurology and the Institute of Neurology, Queen Square, London, UK he took over a position as consultant neurologist and Associate Professor of Neurology at Rostock University, Rostock, Germany. In September 2008 he was appointed Full Professor of Neurology and Head of Movement Disorders Section at the Department of Neurology, Hannover Medical School, Hannover, Germany. He is one of the pioneers of botulinum toxin therapy in Europe. He published over 400 articles, book chapters and abstracts as well as several books on dystonia, other movement disorders and on botulinum toxin therapy. He received an honorary professorship of the University of Santiago de Chile for his contributions to the development of botulinum toxin therapy and holds visiting professorship of the universities of Sao Paulo, Brazil and Monterrey, Mexico. He also holds several patents on botulinum toxin therapy. Dr Dressler is editor and reviewer of several international neurological journals, member of the board of directors of We Move, New York, NY, member of the advisory board of the German Dystonia Society, Hamburg, Bundesverband Torticollis e.V., Hamm, Fundacion Dystonia, Santiago, Chile, Associacao Brasileira de Portadores de Distonias, Sao Paulo, Brazil, the National Spasmodic Torticollis Association, Los Angeles, CA, Swiss Dystonia Society, Basle, Switzerland, as well as member of various international medical societies. He serves as project reviewer for The Wellcome Trust, London, UK and the National Medical Research Council, Singapore.